Sequential Skin — New York, New York

Sequential Skin is a clinical research site located in New York, New York, United States 10013.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Sequential Skin has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Atopic Dermatitis (AD).

Sponsors: Good Molecules, LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sequential Skin?

Sequential Skin has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sequential Skin conducted?

Sequential Skin has 1 clinical trials on record, with 1 currently active. Their work covers Atopic Dermatitis (AD).

Is Sequential Skin accredited by Crixeo Health?

Sequential Skin has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sequential Skin?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.